Donald J. Hayden Jr.
EVP and President, Americas, Bristol-Myers Squibb.
Companies
- Theseus Pharmaceuticals, Inc.Board member May 18, 2022 to Feb 14, 20241
- REGENXBIO Inc.Board member Sep 16, 2015 to Jun 2, 20202
- INSMED IncBoard member Dec 7, 2010 to Apr 11, 20193
- Amicus TherapeuticsBoard member May 30, 2007 to Jun 11, 20184
- Bristol-Myers SquibbEVP and President, Americas Sep 12, 2003 to Mar 3, 20055
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bristol-Myers Squibb BMY212,519 shares6$13.0M at $60.95Mar 3, 2005- Theseus Pharmaceuticals, Inc.0 shares7Feb 14, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 14, 2024U 10,000 shares of Theseus Pharmaceuticals, Inc.7
- Dec 30, 2022Bought 9,900 shares at $5.00 of Theseus Pharmaceuticals, Inc.8
- Dec 29, 2022Bought 100 shares at $5.00 of Theseus Pharmaceuticals, Inc.8
- Mar 1, 2005Granted 16,667 shares of Bristol-Myers Squibb6
- Dec 1, 2004Shares withheld for tax 5,174 shares at $23.64 of Bristol-Myers Squibb9
- Mar 2, 2004Granted 18,333 shares of Bristol-Myers Squibb10
- Dec 1, 2003Shares withheld for tax 5,127 shares at $26.63 of Bristol-Myers Squibb11
- Sep 10, 2003Granted 50,000 shares of Bristol-Myers Squibb12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARREGENXBIO Inc., Board member
- 3SEC EDGARINSMED Inc, Board member
- 4SEC EDGARAmicus Therapeutics, Board member
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jan 3, 2023
- 9SEC EDGARForm 4 filed Dec 3, 2004
- 10SEC EDGARForm 4 filed Mar 4, 2004
- 11SEC EDGARForm 4 filed Dec 2, 2003
- 12SEC EDGARForm 4 filed Sep 12, 2003